---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-061701"
form_type: "8-K"
ticker: "NDRA"
cik: "0001681682"
company_name: "ENDRA Life Sciences Inc."
filed_at: "2026-05-28T10:07:05+00:00"
generated_at: "2026-05-28T10:10:50.633392+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# ENDRA raises $3.8M via private placement; believes it regains Nasdaq compliance

## Summary
- Gross proceeds ~$3.8M from sale of 578,387 shares (or prefunded warrants) and 1,156,774 warrants at $6.57 per unit.
- Side letter restricts cash use until strategic alternative closes or payment obligation met; grants board observer right.
- Nasdaq notified company of non-compliance on Apr 20, 2026; after offering, company believes equity exceeds $2.5M minimum.
- Offering expected to close May 28, 2026; placement agent Lucid Capital Markets.
- Proceeds for working capital and general corporate purposes.

## SEC filing metadata
- accession: 0001213900-26-061701
- form_type: 8-K
- ticker: NDRA
- cik: 0001681682
- company_name: ENDRA Life Sciences Inc.
- filed_at: 2026-05-28T10:07:05+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1681682/000121390026061701/0001213900-26-061701-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1681682/000121390026061701/ea0292216-8k_endra.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-061701
- JSON: https://secwatch.observer/filing/0001213900-26-061701.json
- Plain text: https://secwatch.observer/filing/0001213900-26-061701.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.